Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 17795-21-0
2. Sodium 1h-pyrazolo[3,4-d]pyrimidin-4-olate
3. Sodium Allopurinol
4. Allopurinol Sodium Salt
5. Aloprim
6. Sodium;1h-pyrazolo[3,4-d]pyrimidin-4-olate
7. Allopurinol Sodium (aloprim)
8. 1,5-dihydro-4h-pyrazolo(3,4-d)pyrimidin-4-one, Monosodium Salt
9. 428673rc2z
10. Einecs 241-771-5
11. Nsc 108836
12. Unii-428673rc2z
13. 1h-pyrazolo(3,4-d)pyrimidin-4-ol, Monosodium Salt
14. 4h-pyrazolo(3,4-d)pyrimidin-4-one, 1,5-dihydro-, Monosodium Salt
15. Allopurinolsodium
16. Schembl17223898
17. 1,5-dihydro-4h-pyrazolo[3,4-d]pyrimidin-4-one,monosodiumsalt
18. Akos015899245
19. Ac-4257
20. Sodium 1h-pyrazolo[3,4-d]pyrimidine-4-olate
21. F76872
22. A881435
23. Q27258510
| Molecular Weight | 158.09 g/mol |
|---|---|
| Molecular Formula | C5H3N4NaO |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 0 |
| Exact Mass | 158.02045501 g/mol |
| Monoisotopic Mass | 158.02045501 g/mol |
| Topological Polar Surface Area | 77.5 Ų |
| Heavy Atom Count | 11 |
| Formal Charge | 0 |
| Complexity | 136 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 4 | |
|---|---|
| Drug Name | Allopurinol sodium |
| PubMed Health | Allopurinol (Injection) |
| Drug Classes | Antigout, Urinary Stone Agent |
| Active Ingredient | Allopurinol sodium |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 500mg base/vial |
| Market Status | Prescription |
| Company | Eurohlth Intl |
| 2 of 4 | |
|---|---|
| Drug Name | Aloprim |
| Active Ingredient | Allopurinol sodium |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 500mg base/vial |
| Market Status | Prescription |
| Company | Mylan Institutional |
| 3 of 4 | |
|---|---|
| Drug Name | Allopurinol sodium |
| PubMed Health | Allopurinol (Injection) |
| Drug Classes | Antigout, Urinary Stone Agent |
| Active Ingredient | Allopurinol sodium |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 500mg base/vial |
| Market Status | Prescription |
| Company | Eurohlth Intl |
| 4 of 4 | |
|---|---|
| Drug Name | Aloprim |
| Active Ingredient | Allopurinol sodium |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 500mg base/vial |
| Market Status | Prescription |
| Company | Mylan Institutional |
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Allopurinol Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Allopurinol Sodium, including repackagers and relabelers. The FDA regulates Allopurinol Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Allopurinol Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Allopurinol Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Allopurinol Sodium supplier is an individual or a company that provides Allopurinol Sodium active pharmaceutical ingredient (API) or Allopurinol Sodium finished formulations upon request. The Allopurinol Sodium suppliers may include Allopurinol Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Allopurinol Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Allopurinol Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Allopurinol Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Allopurinol Sodium GMP manufacturer or Allopurinol Sodium GMP API supplier for your needs.
A Allopurinol Sodium CoA (Certificate of Analysis) is a formal document that attests to Allopurinol Sodium's compliance with Allopurinol Sodium specifications and serves as a tool for batch-level quality control.
Allopurinol Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Allopurinol Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Allopurinol Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Allopurinol Sodium EP), Allopurinol Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Allopurinol Sodium USP).
LOOKING FOR A SUPPLIER?
